Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on October 5, 2026

Aprea Therapeutics to Present at October Conferences
Axe Compute Takes Full Ownership of Georgia AI Cluster, Significantly Increasing the Contract’s Expected Free Cash Flow and Gross Margin
Navitas and Microchip Collaborate to Deliver 800V Reference Design for Next-Generation AI Data Centers
Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026
SAIC Acquires Information Security Corporation, Expanding Zero-Trust, Post-Quantum Cryptography and Encryption Capability
DLH Wins $2 Million NIH Data Governance Pilot Task Order
Zorronet Ltd. Announces Joint Framework Agreement with Tier 1 Israeli IT Integrator
Reliance Global Group Becomes Debt Free Following Retirement of 100% of Its Term Debt
TeraWulf Expands Contracted Power Capacity at its Muskie Data Campus to 1 GW
Music Industry Community Brings Music, Networking, and Industry Connections to Chase Bell and LIRA’s “Do Me” Live Experience
Concentrix (NASDAQ: CNXC) Investor Alert: Johnson Fistel Investigates Following Revenue Outlook Cuts and $1.05 Billion Goodwill Impairment
Integra LifeSciences (NASDAQ: IART) Investor Alert: Johnson Fistel Investigates Following Flooding-Related Outlook Cuts and 21% Stock Decline
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
ASML reports transactions under its current share buyback program
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
Ensimmäinen potilas on saanut hoitoa Orion Pharman Faasi 1/2 -tutkimuksessa ODM-216-molekyylillä, joka on yhtiön ensimmäinen kliiniseen kehitysvaiheeseen edennyt biologinen syöpälääkeaihio
PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
4DMT to Host Investor Day on October 21, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.